Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 21, 2019
.jpeg)
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
Regulatory T cells maintain “virtual” immunologic memory
From the Lund lab, Vaccine and Infectious Disease Division
Deep mutational scanning predicts pandemic influenza sequences
From the Bedford and Bloom labs, Vaccine and Infectious Disease and Basic Sciences Divisions
Machine learning predicts HIV pseudovirus antibody neutralization
From the Gilbert group, Vaccine and Infectious Disease Division
Blood micronutrients as biomarkers for major diseases
From the Nutrition and Physical Activity Assessment group, Public Health Sciences Divisions
Phylogenic trees inspire model for neurite measurement
From the Zhu lab, Vaccine and Infectious Disease Division
T cells as biomarkers for hepatitis B disease prognosis
From the Newell lab, Vaccine and Infectious Disease Division
First licensed dengue vaccine withstands rainy season
From the Vaccine and Infectious Disease Division
Modified HIV immunogens engage neutralizing antibody precursors
From the Stamatatos lab, Vaccine and Infectious Disease Division
Genetically diverse mice provide clues for West Nile virus protection
From the Lund lab, Vaccine and Infectious Disease Division
Despite early rise, longterm ART decreases HSV shedding
From the Corey lab, Vaccine and Infectious Disease Division
Predicting lower respiratory disease in transplant patients
From the Boeckh lab, Vaccine and Infectious Disease Division
HIV status among patients at the Uganda Cancer Institute
From the Global Oncology program, Vaccine and Infectious Disease Division
Forecasting the shape of flu viruses to come
‘Deep mutational scanning’ to make a better flu vaccine
Scanning hemagglutinin to predict the future of flu
From the Bloom Lab, Basic Sciences Division and Bedford Lab, Vaccine and Infectious Disease Division
Closer is better
From the Gilbert group, Vaccine and Infectious Disease Division
Fred Hutch deepens its focus on the microbiome
Microbiome Research Initiative hosts 2-day symposium
Wild-type vs. modification: which is better?
From Stamatatos Laboratory, Vaccine and Infectious Disease Division
Serotype is serious business for Dengue infection
From Gilbert Laboratory, Vaccine and Infectious Disease Division
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer